Long-term persistent symptoms of COVID-19 infection in patients with diabetes mellitus

OBJECTIVE: The study aimed to assess the long-term persistent symptoms of patients with diabetes mellitus (DM) and COVID-19 infection at 9 months after acute infection. METHODS: This single-center cross-sectional study was conducted from May 20 to June 1, 2021. RESULTS: A total of 112 patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Mechi, Ahmed, Al-Khalidi, Alhan, AL-Darraji, Rasha, Al-Dujaili, Mohammed Noori, Al-Buthabhak, Karrar, Alareedh, Mohammed, Shaghee, Foaad, Nafakhi, Hussein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Short Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382933/
https://www.ncbi.nlm.nih.gov/pubmed/34456528
http://dx.doi.org/10.1007/s13410-021-00994-w
Descripción
Sumario:OBJECTIVE: The study aimed to assess the long-term persistent symptoms of patients with diabetes mellitus (DM) and COVID-19 infection at 9 months after acute infection. METHODS: This single-center cross-sectional study was conducted from May 20 to June 1, 2021. RESULTS: A total of 112 patients were included in the present study. The most frequently reported persistent symptoms among DM group were fatigue (p = 0.01), shortness of breath (p = 0.01), and chest pain (p = 0.02) compared to non-DM group. Sulfonylurea use was associated with persistent cough (p = 0.04). CONCLUSION: Long-term persistent symptoms of COVID-19 infection are common among patients with DM.

Ejemplares similares